Descriptive statistical analyses of serial dilution data.

The serial dilution assay (for example, an in vitro antimicrobic susceptibility test or a serum antibody titer assay) is an important technique in biomedical research. The structure of the experiment forces grouping of the threshold concentrations into intervals. Statistical methods to analyse threshold concentrations from a batch of serial dilution assays should account for the grouping of the data. Many traditional subject area analyses, however, ignore the grouped nature of the data. This article discusses the discrepancy between the traditional subject area approach and the usual statistical approach for analysing such grouped data.

[1]  A L Barry,et al.  In vitro evaluation of A-56619 and A-56620, two new quinolones , 1986, Antimicrobial Agents and Chemotherapy.

[2]  C Thornsberry,et al.  Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae , 1985, Antimicrobial Agents and Chemotherapy.

[3]  J M Campos,et al.  Effect of NaCl supplementation of Mueller-Hinton broth on susceptibility of staphylococci to aminoglycosides , 1986, Antimicrobial Agents and Chemotherapy.

[4]  G D Overturf,et al.  Analysing antibody response based on data obtained from serial dilution methods. , 1983, Statistics in medicine.

[5]  V. Lorian,et al.  Determination of the range of antibacterial activity by use of viable counts , 1982, Journal of clinical microbiology.

[6]  A L Barry,et al.  In vitro evaluation of Augmentin by broth microdilution and disk diffusion susceptibility testing: regression analysis, tentative interpretive criteria, and quality control limits , 1983, Antimicrobial Agents and Chemotherapy.

[7]  E. Ayoub,et al.  Synergy between penicillins and low concentrations of gentamicin in the killing of group B streptococci. , 1985, The Journal of infectious diseases.

[8]  P. Echeverria,et al.  Comparative study of ceftriaxone and trimethoprim-sulfamethoxazole for the treatment of chancroid in Thailand. , 1985, The Journal of infectious diseases.

[9]  M. Pfaller,et al.  Activity of Ketoconazole and Its Deacyl Derivative Against Plasmodium falciparum and Candida Isolates , 1982, Antimicrobial Agents and Chemotherapy.

[10]  A. Espinel-Ingroff,et al.  Comparison of the in vitro antifungal activities of miconazole and a new imidazole, R41,400. , 1978, The Journal of infectious diseases.

[11]  T. Bergan,et al.  In vitro activity of antifungal agents against yeast species. , 1983, Chemotherapy.

[12]  Patrick R. Murray Antibiotic Susceptibility Testing. Part It , 1983 .

[13]  P. Turgeon,et al.  Stability of imipenem in Mueller-Hinton agar stored at 4 degrees C , 1985, Antimicrobial Agents and Chemotherapy.

[14]  A S Bayer,et al.  Efficacy of amikacin and ceftazidime in experimental aortic valve endocarditis due to Pseudomonas aeruginosa , 1985, Antimicrobial Agents and Chemotherapy.

[15]  R. Wallace,,et al.  Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities. , 1985, The Journal of infectious diseases.

[16]  L. Jokipii,et al.  Comparative evaluation of the 2-methyl-5-nitroimidazole compounds dimetridazole, metronidazole, secnidazole, ornidazole, tinidazole, carnidazole, and panidazole against Bacteroides fragilis and other bacteria of the Bacteroides fragilis group , 1985, Antimicrobial Agents and Chemotherapy.

[17]  F E Tosh,et al.  Epidemiologic and laboratory investigation of an outbreak of Campylobacter enteritis associated with raw milk. , 1985, American journal of epidemiology.

[18]  W. Dismukes,et al.  Treatment of systemic mycoses with ketoconazole: in vitro susceptibilities of clinical isolates of systemic and pathogenic fungi to ketoconazole. , 1985, The Journal of infectious diseases.